Rare Disease Company Coalition

Based in DC

Share:𝕏LinkedInFacebook
🤖

AI Overview

With $960K in lobbying spend across 15 quarterly filings, Rare Disease Company Coalition is an active lobbying client. Their lobbying covers 3 issue areas. Active from 2021 to 2024.

$960K
Total Spend
4
Years Active
0
Firms Hired
0
Lobbyists Deployed
3
Issues Lobbied

Issues Lobbied

Health IssuesPharmacyMedicare/Medicaid

Related Analysis

📈 Client Trajectories
See how this client compares to others over time
🎯 Market Concentration
How concentrated is the lobbying market?
🚀 Spending Momentum
Which issues are surging right now?
🏭 Pharma Lobbying
Industry overview and top spenders

Related Investigations

Big Pharma's $452M Lobbying Machine
How pharmaceutical companies spend hundreds of millions to influence health policy.
Healthcare's $3 Billion Bet
The healthcare industry's massive lobbying investment.
Federal Lobbying Statistics 2025
The definitive stats — $15.2B total, industry breakdowns, and trends.
What Is Lobbying? A Complete Guide
How lobbying works, who does it, and why it matters.

Explore More

← All Clients⚖️ Compare Clients💵 ROI Calculator🔍 Investigations📖 How Lobbying Works🕸️ Network Analysis

Data Sources: Senate LDA Filings

Last updated: February 2026

This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.